Morgan Stanley has downgraded Ardent Health Inc (ARDT) to Equal-Weight from Overweight, reflecting a more cautious outlook on the company's future performance. This decision, made on November 13, 2025, comes as the healthcare provider navigates potential competitive pressures and market conditions that could affect its operations.
Currently, Ardent Health Inc is trading at $9.30. The company, headquartered in Brentwood, Tennessee, operates a network of 30 acute care hospitals and approximately 280 sites of care across six states. With a market capitalization of $2.1 billion and a P/E ratio of 8.16, it has a workforce of 19,200 employees and is focused on delivering a range of healthcare services, including general and specialty care.
Analyst ratings, such as this downgrade, provide valuable insights but should be considered alongside other factors like company fundamentals and industry trends. As of November 1, 2025, the consensus rating for Ardent Health Inc remains a Buy, with a breakdown of 5 Strong Buy, 10 Buy, 3 Hold, 1 Sell, and no Strong Sell ratings among 19 analysts.
The recent earnings performance also shows promise, with Q3 2025 EPS at $0.52, exceeding estimates by 24.8%. While the downgrade raises questions, it’s essential to remember that analyst opinions can evolve as new information surfaces, and differing views can exist among analysts covering the same stock.